ENDEFR
Home › India › ORCHID BIO-PHARMA LIMITED

ORCHID BIO-PHARMA LIMITED

Public Limited Company (Ltd) · CHENNAI, India · LEI 98450011B7C3HY6A6014
LEI active

Summary

ORCHID BIO-PHARMA LIMITED is registered in India and entered in the “Companies Register (Ministry of Corporate Affairs)” under number U24230TN2022PLC150784. Its legal form is Public Limited Company (Ltd). According to GLEIF, its ultimate parent is DHANUKA LABORATORIES LIMITED (India), and its direct parent is ORCHID PHARMA LIMITED (India). That group has 2 subsidiaries with LEIs in 1 country, 2 of them in India. The LEI was first issued on 24 Jan 2024 and the record was last updated on 21 Jan 2026; the next renewal is due by 24 Jan 2027. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Mar 2024, more than 24 months before this data release. The group may have changed since.

Company details

Legal formPublic Limited Company (Ltd)
RegisterCompanies Register (Ministry of Corporate Affairs) · Register website
Registration numberU24230TN2022PLC150784
Registration authorityMinistry of Corporate Affairs
JurisdictionIndia
Registered address1st Floor (East Portion), Plot No. A10, SIDCO Industrial Estate, Alathur, Chengalpattu, 603110 CHENNAI, India
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)24 Mar 2022
LEI98450011B7C3HY6A6014
LEI statusactive
LEI first issued24 Jan 2024
LEI record last updated21 Jan 2026
Next LEI renewal24 Jan 2027
Corroboration of the LEI recordfully corroborated

Group membership

DHANUKA LABORATORIES LIMITED India ultimate parent
ORCHID PHARMA LIMITED India direct parent
ORCHID BIO-PHARMA LIMITED this entity
View the whole group: 2 subsidiaries in 1 countries

Relationship to the parent

Direct parentUltimate parent
ParentORCHID PHARMA LIMITEDDHANUKA LABORATORIES LIMITED
Accounting period1 Apr 2023 to 31 Mar 20241 Apr 2023 to 31 Mar 2024
Evidenceconsolidated accountsconsolidated accounts
Corroborationsupplied by the entity onlysupplied by the entity only
Accounting standardother standardother standard
Consolidation percentage reported to GLEIF100.00%89.96%
Relationship start24 Mar 202224 Mar 2022
Recorded at GLEIF since24 Jan 202424 Jan 2024
Last updated21 Jan 202621 Jan 2026
Record statuscurrentcurrent